Neutrophils, an emerging new therapeutic platform

Area of Science:

• Immunology
• Hematology
• Gene Therapy

Background:

• Neutrophils are vital immune cells, but irregular counts or functions lead to severe health issues.
• Neutrophils are short-lived, necessitating progenitor-targeted therapies for genetic defects.
• Therapeutic applications for neutrophils are expanding beyond immune support.

Purpose of the Study:

• To review current neutrophil transfusion strategies for infectious diseases.
• To explore gene therapy for inherited neutrophil disorders.
• To discuss novel neutrophil-based therapies for solid tumors and other conditions.

Main Methods:

• Literature review of neutrophil transfusion efficacy.
• Analysis of gene therapy approaches for neutrophil genetic diseases.
• Exploration of emerging research in neutrophil-based cancer treatments.

Main Results:

• Neutrophil transfusions show potential in preventing and treating infections.
• Gene therapy offers a pathway to correct genetic neutrophil defects.
• Neutrophil applications are being explored for solid tumor targeting.

Conclusions:

• Neutrophil transfusions and gene therapy are advancing treatment for neutrophil disorders.
• Emerging research highlights the potential of neutrophil-based therapies in oncology.
• Further investigation is needed to broaden the clinical utility of neutrophil therapies.